DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
当前地点:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

European Radiology profiles Seno Medical's breast cancer diagnostic technology

Jubilant Pharma announces formation of a new business focused on improving lives through nuclear medicine

Sofie expands its network by acquiring Cyclotope Radiopharmacy from Houston Cyclotron Partners

Keynote speakers for the opening day of its annual scientific session this September in Chicago

ANSTO new state-of-the-art nuclear medicine facility gets license

New radiotracer can identify nearly 30 types of cancer

United Imaging announces first U.S. clinical installation of uMI 550 DIGITAL PET/CT System

BGN Technologies introduces novel radioisotope production method for nuclear medicine used in imaging

Philips and University of Vermont Health Network sign 10-year agreement to improve patient care

Theranostics - New hope for late stage prostate cancer patients with an innovative UK-first treatment from GenesisCare

Eden Radioisotopes secures reactor project funding for medical isotope production

Press releases may be edited for formatting or style
ALBUQUERQUE, N.M., May 22, 2019 /PRNewswire/ -- Eden Radioisotopes, LLC, an Albuquerque, NM startup company, is pleased to announce an investment agreement with Abo Empire, LLC, a Yates Family company. This investment funds the company project to build a reactor of less than 2MW in New Mexico for the purpose of producing medical isotopes, primarily Molybdenum-99. Known as Moly-99 for short, this isotope is a critical raw material for Technetium-99m, used extensively in medical molecular imaging, also known as nuclear medicine, around the world.

"We're thrilled to back the Eden team in their mission to provide the world with a dependable supply of Moly-99," says Ryan Price, Vice President of Abo Empire. "This project checks many boxes for us: it diversifies family investment through the economic development of the State of New Mexico, creates high-paying, highly technical jobs for our youth to grow into, and does a lot of good for a lot of people."

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"Molecular Imaging is a $4 billion a year global market," says Chris Wagner, Eden's Chief Operating Officer and former Vice President at both Nordion and Mallinckrodt (n/k/a Curium). "There are 40 million diagnostic molecular imaging procedures performed worldwide each year, of which 80 percent use Technetium-99m, with 90 percent of those being either cardiac or cancer-related. While the imaging procedures performed in the United States represent more than half of the global use of Moly-99, there is no domestic supplier and no readily available alternative for molecular imaging. Reliability of Moly-99 supply is vitally important to US healthcare."

Moly-99 is used by radiopharmaceutical manufacturers worldwide to produce Molybdenum-99/Technetium-99m Generators, which are then shipped to hospitals, clinics, and radiopharmacies. As Moly-99 decays to Technetium-99m, it is then used to make individual patient doses for a variety of diagnostic imaging procedures.

For the past 20 years, the global supply of Moly-99 has been precarious at best. Only five reactors around the world have borne primary responsibility for Moly-99 production; in Canada, The Netherlands, South Africa, Belgium, and Australia. Due to age, these reactors have experienced numerous unplanned outages for repairs, causing shortages and price spikes. The Canadian reactor has already begun the decommissioning process, while the Dutch reactor is almost 60 years old and could soon be reaching the end of its useful life. "Together they represent more than 60 percent of the global supply capacity of Moly-99. With the Canadian reactor now offline, should The Netherlands reactor ever incur a long-term outage before sufficient new replacement capacity becomes available, the molecular imaging industry could experience challenging global supply shortages," says Wagner.
  Pages: 1 - 2 - 3 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
Jobs/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
Recently Certified
查看最近通过认证的用户
Recently Rated
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
Service Technicians Forum
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2019 DOTmed.com, Inc.
版权所有